Business News • PR NewsWire • CTI BioPharma And Fred Hutchinson Cancer Research Center Announce International Research Fellowship To Support Innovative Blood-Related Cancer Research

CTI BioPharma And Fred Hutchinson Cancer Research Center Announce International Research Fellowship To Support Innovative Blood-Related Cancer Research

CTI BioPharma And Fred Hutchinson Cancer Research Center Announce International Research Fellowship To Support Innovative Blood-Related Cancer Research

SEATTLE, Oct. 1, 2015 /PRNewswire/ -- Seattle-based CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) and Fred Hutchinson Cancer Research Center (Fred Hutch) today announced the establishment of a new $1.5 million research endowment fund – The CTI BioPharma...

View More : http://www.prnewswire.com/news-releases/cti-biopharma-and-fred-hutchinson-cancer-research-center-announce-international-...

Releted News by prnewswire

Lexus Expands Relationship with INRIX to Include Weather and Fuel Services

Fibromyalgia Pipeline Review and Fibrositis Market Epidemiology Forecasts to 2023 in New Research Reports